NET INCOME PER SHARE (Tables)

9 Months Ended

Sep. 30, 2013

Net Income Loss Per Share Disclosure [Abstract]

SCHEDULE OF EPS- BASIC AND DILUTED

The following table sets forth the computation of basic and diluted net income per share for the periods indicated:

	For the three months ended
	September 30, 2013	September 30, 2012
	USD	USD
Net income attributable to China Biologic Products, Inc.	14,696,023	13,617,150
Earnings allocated to participating nonvested shares	(143,220)	(20,709)
Net income used in basic/diluted net income per common stock	14,552,803	13,596,441
Weighted average shares used in computing basic net income per common     stock	26,288,154	26,546,929
Diluted effect of stock option	1,160,927	471,975
Weighted average shares used in computing diluted net income per common     stock	27,449,081	27,018,904
Net income per common stock – basic	0.55	0.51
Net income per common stock – diluted	0.53	0.50

	For the nine months ended
	September 30, 2013	September 30, 2012
	USD	USD
Net income attributable to China Biologic Products, Inc.	45,773,809	39,413,227
Earnings allocated to participating nonvested shares	(303,490)	(20,562)
Net income allocated to common stockholders used in computing basic net     income per common stock	45,470,319	39,392,665
Change in fair value of warrants	-	(1,769,140)
Net income used in diluted net income per common stock	45,470,319	37,623,525
Weighted average shares used in computing basic net income per common     stock	26,649,563	26,009,707
Diluted effect of warrants	-	266,999
Diluted effect of stock option	1,130,442	465,007
Weighted average shares used in computing diluted net income per common     stock	27,780,005	26,741,713
Net income per common stock – basic	1.71	1.51
Net income per common stock – diluted	1.64	1.41